---
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/292345271.md"
description: "First Tracks Biotherapeutics shares are trading higher after HC Wainwright & Co. maintained its Buy rating on the stock and raised its price target from $30 to $44."
datetime: "2026-07-10T16:34:46.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/292345271.md)
  - [en](https://longbridge.com/en/news/292345271.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/292345271.md)
generator: "portal-rs"
---

# 

First Tracks Biotherapeutics shares are trading higher after HC Wainwright & Co. maintained its Buy rating on the stock and raised its price target from $30 to $44.

### Related Stocks

- [TRAX.US](https://longbridge.com/en/quote/TRAX.US.md)

## Related News & Research

- [Wolfe Research Begins Coverage on First Tracks Biotherapeutics (NASDAQ:TRAX)](https://longbridge.com/en/news/296233523.md)
- [First Tracks Biotherapeutics Analysts Increase Their Forecasts After Q2 Results](https://longbridge.com/en/news/295805215.md)
- [Cullen/Frost Bankers, Inc. (NYSE:CFR) Given Average Rating of "Hold" by Analysts](https://longbridge.com/en/news/296868075.md)
- [Lenovo Reaches New High in Workplace Pride Benchmark With First 'Advocate' Status](https://longbridge.com/en/news/296906399.md)
- [Q3 Earnings Estimate for OGE Energy Issued By Zacks Research](https://longbridge.com/en/news/296476551.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**